Pharmaceutical Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

Most Read

  1. Draft Brexit withdrawal agreement: what does it mean for the pharma industry?
  2. South Korean regulator publishes final ruling on Samsung BioLogics’ accounting violations
  3. The problem with drug patents: can a new global approach help?
  4. FDA grants priority review to AstraZeneca’s Lynparza for ovarian cancer
  5. Spanish authorities restrict prescription of Nolotil after British patient deaths

Latest Content

Draft Brexit withdrawal agreement: what does it mean for the pharma industry?

This week the UK Government and the European Commission published a draft Brexit withdrawal agreement. Like with every industry, the document has implications for the pharmaceutical industry, including clarification about the lack of disruption to supplies during the transition period and sharing of marketing authorisation information between the UK and EU member states.

The Future of the Pharmaceutical Industry

Ever participated in one of those benchmarking exercises? When a (usually) fresh-faced consultant asks a lot of questions and fills in a spreadsheet comparing what you do with your competitors? Well, beware.

The problem with drug patents: can a new global approach help?

Many countries do not have the equivalent to the US’s Orange book, and as a result health official are waste time establishing whether drug patents have been taken out on medicines. As a solution, leading biopharmaceutical companies, the UN’s World Intellectual Property Organization (WIPO) and the IFPMA have worked together to develop Pat-INFORMED, an innovative global gateway.

FierceBiotech Executive Summit: Brexit remains a major concern for UK pharma

Post-Brexit UK medicines regulations have been a major talking point for the healthcare industry for over two years. With no agreement having yet been reached between the UK and EU on whether the UK will maintain or sever its ties with the European Medicines Agency (EMA), the healthcare industry is still grappling with what to expect from, and how to prepare for, the UK’s departure from the EU on March 29, 2019.

Latest News

Read our magazine

Pharma Technology Focus is the essential reading material for decision-makers in the pharmaceutical industry, bringing you the latest news and analysis in an exciting, interactive format.

Send me notifications of new editions:

Go Top